A new antihypertensive agent: Maxzide (75 mg triamterene/50 mg hydrochlorothiazide)
- 5 November 1984
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 77 (5) , 52-58
- https://doi.org/10.1016/s0002-9343(84)80008-x
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Preliminary observations on dissolution and bioavailability of triamterene–hydrochlorothiazide combination productsBiopharmaceutics & Drug Disposition, 1984
- Pharmacokinetics of triamterene and its metabolite in manJournal of Pharmacokinetics and Biopharmaceutics, 1982
- Hydrochlorothiazide Pharmacokinetics and Pharmacologic Effect: The Influence of IndomethacinThe Journal of Clinical Pharmacology, 1982
- Potassium ReplacementDrugs, 1979
- Pharmacokinetics of hydrochlorothiazide in manEuropean Journal of Clinical Pharmacology, 1977
- Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy.Heart, 1976
- The influence of dosage form on the activity of a diuretic agentClinical Pharmacology & Therapeutics, 1968
- Ectopic Beats and Atrioventricular Conduction DisturbancesArchives of internal medicine (1960), 1967
- Serum Potassium and the Electrocardiogram in HypokalemiaCirculation, 1960
- Quantitative Analysis of the Electrocardiographic Pattern of HypopotassemiaCirculation, 1957